🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial will evaluate the impact of 4 weeks of postoperative essential a...
Status
Recruiting
Location
University of Iowa Health Care
Start Date
2024-06-17
Trial ID
NCT06050668
Treatments Being Tested
The purpose of this study is to determine whether a supplementation contain...
Status
Completed
Location
University of Padova
Start Date
2014-02
Trial ID
NCT02118181
Treatments Being Tested
Patients suffering from cancer often experience a loss of muscle mass and s...
Status
Unknown
Location
Hector-Center for Nutrition, Exercise and Sports
Start Date
2016-12
Trial ID
NCT03151291
This is a pilot study of β-hydroxy-β-methylbutyrate (HMB) + Vitamin D3 supp...
Status
Unknown
Location
Gillette Children's Specialty Healthcare
Start Date
2022-05-15
Trial ID
NCT05384951
Treatments Being Tested
During middle-age, humans begin to lose muscle mass and strength. With incr...
Status
Unknown
Location
Freer Hall
Start Date
2019-04-01
Trial ID
NCT03848741
Treatments Being Tested
This study aimed to conduct a double-blind randomized pragmatic trial to ev...
Status
Completed
Location
Faculty of Human Kinetics
Start Date
2017-05-29
Trial ID
NCT03511092
Treatments Being Tested
The proposed project will evaluate the musculoskeletal outcomes of quadrice...
Status
Recruiting
Location
University of Kansas Health System
Start Date
2023-05-29
Trial ID
NCT05869812
Treatments Being Tested
This study is to evaluate the effect of CaHMB in the treatment of sarcopeni...
Status
Unknown
Location
Shanghai Zhongshan Hospital
Start Date
2018-08-22
Trial ID
NCT03605147
The purpose of this study was to verify the effect of 12-week with β-hydrox...
Status
Completed
Location
Poznan University of Life Sciences, ul.Wojska Polskiego 31
Start Date
2010-01
Trial ID
NCT03028649
Treatments Being Tested
This is a prospective parallel group, double-blinded randomized controlled ...
Status
Completed
Location
Kowloon Hospital
Start Date
2022-09-09
Trial ID
NCT06287502